Skip to main content
. Author manuscript; available in PMC: 2023 Apr 20.
Published in final edited form as: Diabetes Res Clin Pract. 2020 Dec 15;171:108624. doi: 10.1016/j.diabres.2020.108624

Table 2 -.

Characteristics of individuals in the population at risk, overall and by incident diabetes status in 2017: The DiYA study.

Population at Risk on 1/1/2017 Diabetes Status at end of 2017
Diabetes No Diabetes

N
Sex, n (%)
2,347,989 7,862 2,340,127
Male 1,133,031 (48.3) 4313 (54.9) 1,128,718 (48.2)
Female 1,214,847 (51.7) 3549 (45.1) 1,211,298 (51.8)
Other/Unknown 111 (0.0) 0 (0.0) 111 (0.0)
Age, years, mean (SD)
Age Categories, years, n (%)
31.5 (7.5) 36.8 (6.0) 31.5 (7.5)
Age 20–24 564,390 (24.0) 400 (5.1) 563,990 (24.1)
Age 25–29 412,323 (17.6) 611 (7.8) 411,712 (17.6)
Age 30–34 462,358 (19.7) 1397 (17.8) 460,961 (19.7)
Age 35–39 467,922 (19.9) 2234 (28.4) 465,688 (19.9)
Age 40–45 440,996 (18.8) 3220 (41.0) 437,776 (18.7)
Race/Ethnicity, n (%) *
Hispanic (regardless of race) 812,462 (34.6) 3882 (49.4) 808,580 (34.6)
White (non-Hispanic) 780,012 (33.2) 1381 (17.6) 778,631 (33.3)
Asian 360,861 (15.4) 1380 (17.6) 359,481 (15.4)
Black (non-Hispanic) 164,205 (7.0) 640 (8.1) 163,565 (7.0)
Other race/ethnicity/missing 212,341 (9.0) 579 (7.4) 236,170 (10.1)
BMI nearest to 1/1/17, mean ± SD
BMI, kg/m2, n (%)
28.3 (6.72) 37.0 (8.72) 28.3 (6.69)
BMI < 18.5 32,622 (1.4) 7 (0.1) 32,615 (1.4)
BMI 18.5–24.9 648,209 (27.6) 368 (4.7) 647,841 (27.7)
BMI 25–29.9 608,465 (25.9) 1270 (16.2) 607,195 (25.9)
BMI 30–35.9 346,943 (14.8) 1952 (24.8) 344,991 (14.7)
BMI 35+ 277,797 (11.8) 4233 (53.8) 273,564 (11.7)
Missing 433,953 (18.5) 32 (0.4) 433,921 (18.5)
Insurance type, n (%)
Commercial 2,055,397 (87.5) 6961 (88.5) 2,048,436 (87.5)
Medicaid, Medicare or state-subsidized 168,782 (7.2) 647 (8.2) 168,135 (7.2)
Private pay or Self-funded 74,984 (3.2) 165 (2.1) 74,819 (3.2)
Other/Missing 48,826 (2.1) 89 (1.2) 48737(2.1)
Median household Income in census block, US$ mean ± SD
Median household income, US$, n (%)
75,268 (31324) 68,681 (28369) 75,291 (31331)
<$30,000 67,646 (2.9) 280 (3.6) 67,366 (2.9)
$30–<50 K 453,957 (19.3) 2030 (25.8) 451,927 (19.3)
$50–<75 K 768,813 (32.7) 2756 (35.1) 766,057 (32.7)
$75 < 100 K 567,747 (24.2) 1666 (21.2) 566,081 (24.2)
$100 < 150 K 423,688 (18.0) 1006 (12.8) 422,682 (18.1)
$150,000+ 51,197 (2.2) 92 (1.2) 51,105 (2.2)
Missing 14,941 (0.6) 32 (0.4) 14,909 (0.6)
Diabetes Medication
No diabetes medications 1936 (24.6)
Insulin +/− other diabetes medication 728 (9.3)
Other non-insulin diabetes medication(s) 5198 (66.1)
Diabetes type based on majority of ICD-10-CM codes
Type 1 126 (1.6)
Type 2 7710 (98.1)
Other type or unknown  26 (0.3)
*

Other race/ethnicity (% of total population) includes Multiple Race (1.4%), Pacific Islander (0.9%), “Other Race” (0.8%), and Native American (0.3%).

In the 365 days after diabetes diagnosis.

Of the 26 individuals categorized as other diabetes type or unknow, 9 individuals had >50% of their codes for diabetes types other than type 1 diabetes or type 2 diabetes, 12 had equal numbers of codes for type 1 diabetes and type 2 diabetes or type 2 diabetes and other diabetes type, and 5 had codes for three types of diabetes, none of which exceeded 50% of the ICD-10 codes.